GMO Product Platform, Inc. carries a market capitalization of 6.30B, placing it among publicly traded companies globally. Its enterprise value stands at 3.71B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 6.30B |
| Enterprise Value | 3.71B |
GMO Product Platform, Inc. currently has 1.63M shares outstanding.
| Shares Outstanding | 1.63M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
GMO Product Platform, Inc. trades at a trailing price-to-earnings ratio of 20.73. The price-to-sales ratio is 0.93, and the price-to-book ratio stands at 2.98.
| PE Ratio | 20.73 |
| PS Ratio | 0.93 |
| PB Ratio | 2.98 |
| P/TBV Ratio | 2.75 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, GMO Product Platform, Inc. trades at an EV/EBITDA multiple of 12.08 and an EV/FCF ratio of 8,857.38. The EV/Sales ratio of 0.74 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 12.08 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.74 |
| EV / EBITDA | 12.08 |
| EV / EBIT | 12.08 |
| EV / FCF | 8,857.38 |
GMO Product Platform, Inc. maintains a current ratio of 2.51, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.35, indicating conservative leverage, while an interest coverage ratio of 567.55 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.51 |
| Quick Ratio | 1.03 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | 0.02 |
| Interest Coverage | 567.55 |
GMO Product Platform, Inc. posts a return on equity of 14.53 and a return on invested capital of 11.87.
| Return on Equity (ROE) | 14.53 |
| Return on Assets (ROA) | 7.72 |
| Return on Invested Capital (ROIC) | 11.87 |
| Return on Capital Employed (ROCE) | 14.15 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 38.25 |
Over the trailing twelve months, GMO Product Platform, Inc. has paid 66.81M in income taxes, reflecting an effective tax rate of 22.59.
| Income Tax | 66.81M |
| Effective Tax Rate | 22.59 |
GMO Product Platform, Inc.'s stock has declined approximately -43.81625% over the past 52 weeks. The 50-day moving average sits at 1,622.06, while the 200-day moving average is 1,862.09.
| Beta (5Y) | N/A |
| 52-Week Price Change | -43.81625% |
| 50-Day Moving Average | 1,622.06 |
| 200-Day Moving Average | 1,862.09 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, GMO Product Platform, Inc. generated 5.00B in revenue and converted that into 224.58M in net income, yielding earnings per share of 140.09. EBITDA reached 307.05M, while operating income came in at 307.05M.
| Revenue | 5.00B |
| Gross Profit | 2.50B |
| Operating Income | 307.05M |
| Pretax Income | 295.71M |
| Net Income | 224.58M |
| EBITDA | 307.05M |
| EBIT | 307.05M |
| Earnings Per Share (EPS) | 140.09 |
GMO Product Platform, Inc. holds 958.72M in cash and equivalents against 7.06M in total debt, resulting in a net debt position of -958.72M. Total book value stands at 1.56B, with working capital of 1.40B providing operational flexibility.
| Cash & Cash Equivalents | 958.72M |
| Total Debt | 7.06M |
| Net Debt | -958.72M |
| Equity (Book Value) | 1.56B |
| Book Value Per Share | 957.22 |
| Working Capital | 1.40B |
GMO Product Platform, Inc. operates with a gross margin of 50.00, reflecting its pricing power and cost economics. The operating margin of 6.14 and net profit margin of 4.49 provide insight into operational efficiency.
| Gross Margin | 50.00 |
| Operating Margin | 6.14 |
| Pretax Margin | 5.91 |
| Profit Margin | 4.49 |
| EBITDA Margin | 6.14 |
GMO Product Platform, Inc. posts an Altman Z-Score of 6.55, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 6.55 |